Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization. Zhang QY, Zhang HQ, Zhang YN, Zhang ZR, et al. Antiviral Res 2023 Nov 18:105757. doi: 10.1016/j.antiviral.2023.105757.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang QY, Zhang HQ, Zhang YN, Zhang ZR, et al. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization. Antiviral Res 2023 Nov 18:105757. doi: 10.1016/j.antiviral.2023.105757.
PMID: 37984567